News Daily News Una Dosis Alta de Aspirina tras una PCI Primaria aumenta las Hemorragias No observandose Beneficio Isquémico alguno L.A. McKeown December 19, 2012
News Daily News High-Dose Aspirin After Primary PCI Increases Bleeding with No Ischemic Benefit L.A. McKeown December 19, 2012
News Daily News Clopidogrel Pretreatment Reduces Cardiac Events, Not Mortality, After PCI Yael L. Maxwell December 19, 2012
News Daily News Los betabloqueadores reducen la mortalidad a largo plazo en pacientes de alto riesgo de STEMI Yael L. Maxwell December 13, 2012
News Daily News Beta-Blockers Reduce Long-term Mortality in High-Risk STEMI Patients Yael L. Maxwell December 13, 2012
News Daily News Extended Dual Antiplatelet Therapy Lowers Death, MI Rates in DES Patients Jason Kahn December 05, 2012
News Daily News Bivalirudin Shows Advantage Over GPIs—But Not Heparin Alone—in STEMI Patients L.A. McKeown November 28, 2012
News Daily News La Bivalirudina Reduce las Hemorragias en Pacientes NSTEMI sometidos a PCI Jason Kahn October 19, 2012
News Daily News Bivalirudin Lowers Bleeding in NSTEMI Patients Undergoing PCI Jason Kahn October 19, 2012
News Daily News La Dosis de Carga Doble de Clopidogrel No Ofrece Beneficio Alguno en Pacientes con ERC que se someten a PCI Primarias L.A. McKeown September 18, 2012
News Daily News Double Clopidogrel Loading Dose Offers No Benefit in Primary PCI Patients with CKD L.A. McKeown September 18, 2012
News Conference News ESC 2012 Prolonged Vorapaxar Enhances Secondary Prevention in Selected Post-MI Patients August 26, 2012
News Conference News ESC 2012 Comparable Long-Term Safety, Efficacy with Prasugrel, Clopidogrel in ACS August 26, 2012
News Daily News Stopping Clopidogrel 1 Year After MI Raises Risk in PCI Patients Jason Kahn July 20, 2012
News Daily News Interrumpir el Clopidogrel 1 Año después de un IM Aumenta el Riesgo en Pacientes sometidos a PCI Jason Kahn July 20, 2012
Presentation Clopidogrel Discontinuation After Myocardial Infarction and Risk of Thrombosis Presenter: Mette Charlot July 19, 2012
News Daily News Las Directrices Elevan el Ticagrelor a la Categoría de Antiplaquetario de 1ª Línea contra la Angina Inestable Jason Kahn July 17, 2012
News Daily News Guidelines Elevate Ticagrelor to First-line Antiplatelet Status in Unstable Angina Jason Kahn July 17, 2012
News Daily News HORIZONS-AMI: Similar Outcomes with Abciximab, Eptifibatide During Primary PCI July 05, 2012